Kokkevi Anna, Fotiou Anastasios, Richardson Clive
University Mental Health Research Institute, Athens, Greece.
Eur Addict Res. 2007;13(3):167-76. doi: 10.1159/000101553.
The evolution of the drug use epidemic in Greece (prevalence and incidence of use of illicit drugs and illicit use of psychoactive pharmaceuticals) over a 20-year period is presented taking into account the sociocultural context and policies. Data were drawn from face-to-face household surveys carried out in 1984, 1998 and 2004 on national stratified probability samples of approximately 4,000 participants aged 12-65 years. After a large increase in lifetime illicit drug use prevalence from 4.0% in 1984 to 12.2% in 1998, the phenomenon seems to have taken a downward turn, to 8.6% in 2004. The incidence of illicit drug use remained unchanged between 1998 and 2004 in adolescents, declined in the young adult group (18-24 years) and dropped sharply at older ages. Cannabis accounts for almost all the total prevalence of illicit drug use; other illicit drugs have lifetime prevalence below 1%. The large gender differences in illicit drug use have narrowed over the years, especially in the younger age groups, although males remain far more heavily involved in illicit drug use than females. The lifetime prevalence of unprescribed use of pharmaceuticals has decreased markedly over the last 20 years from 13.5 to 9.1% following a stricter policy on prescribing. A narrowing of gender differences was also observed here, although females continue to predominate. Findings from the Greek general population surveys have had an impact on drug policy in the past and continue to represent an important input to policy formulation.
本文结合社会文化背景和政策,呈现了希腊20年间药物使用流行情况(非法药物使用及精神活性药物非法使用的患病率和发病率)的演变。数据来自于1984年、1998年和2004年对全国分层概率样本进行的面对面家庭调查,样本为约4000名年龄在12 - 65岁的参与者。终生非法药物使用患病率从1984年的4.0%大幅上升至1998年的12.2%后,这一现象似乎出现了下降趋势,2004年降至8.6%。1998年至2004年间,青少年非法药物使用发病率保持不变,年轻成年人组(18 - 24岁)有所下降,而在年龄较大人群中则急剧下降。大麻几乎占非法药物使用总患病率的全部;其他非法药物的终生患病率低于1%。多年来,非法药物使用中的巨大性别差异有所缩小,尤其是在较年轻年龄组中,尽管男性在非法药物使用方面的参与程度仍远高于女性。在过去20年中,随着更严格的处方政策出台,未按处方使用药物的终生患病率从13.5%显著下降至9.1%。这里也观察到性别差异在缩小,尽管女性仍然占主导地位。希腊普通人群调查的结果过去曾对药物政策产生影响,并且继续是政策制定的重要依据。